Padlock Therapeutics is Drug Discovery in United States that focus on epigenetic control business. Founded in 2014. They cover business area such as provider, developer, novel drug, this company, novel therapeutic, protein arginine, an emerge class, enzyme, role, autoimmunity, epigenetic control.
2014
( 10 years old in 2024 )
Epigenetic Control
-
200 Cambridge Park Drive
Cambridge, MA 02140
United States
Private
providerdevelopernovel drugthis companynovel therapeuticprotein argininean emerge classenzymeroleautoimmunityepigenetic control
* We use standard office opening hours in near Padlock Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Padlock Therapeutics is Drug Discovery business from United States that founded in 2014 (10 years old in 2024), Padlock Therapeutics business is focusing on Epigenetic Control.
Padlock Therapeutics headquarter office and corporate office address is located in 200 Cambridge Park Drive Cambridge, MA 02140 United States.
Padlock Therapeutics was founded in United States.
In 2024, Padlock Therapeutics is currently focus on epigenetic control sector.
Above is snippet of Google Trends for "epigenetic control" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Padlock Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
